Работы, на которые ссылается эта работа
Работ: 361
Работа: Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers
Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Обзорная статья2025Цитирований: 6ABIUse of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Статья2020Цитирований: 6ABIRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi, Matthew H. Larson, Luke A. Gilbert +4
Статья2013Цитирований: 3ABIDelivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney +1
Обзорная статья2018Цитирований: 3ABITisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster, Michael Bishop, Constantine S. Tam +21
Статья2018Цитирований: 3ABITisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner +32
Статья2018Цитирований: 3ABICAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3
Обзорная статья2022Цитирований: 3ABIHigh-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu, Jennifer A Foden, Cyd Khayter +4
Статья2013Цитирований: 2ABIProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Nicole M. Gaudelli, Alexis C. Komor, Holly A. Rees +4
Статья2017Цитирований: 2ABICRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38
Статья2020Цитирований: 2ABIEpigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy
Rajkumar Prabhakaran, Rajkumar Thamarai, Sivabalan Sivasamy +6
Обзорная статья2024Цитирований: 2ABI“Galectin-9: A double-edged sword in Acute Myeloid Leukemia”
Omolbanin Sargazi-Aval, Ali Ahmadi, Ali Jihad Hemid Al-Athari +5
Обзорная статья2025Цитирований: 2ABIInsights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies
Sara Zehtabcheh, Hamed Soleimani Samarkhazan, Marjan Asadi +3
Обзорная статья2025Цитирований: 2ABIC-type lectin-like molecule-1 as a diagnostic, prognostic, and therapeutic marker in leukemia
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Sajjad Peyvasteh +1
Обзорная статья2025Цитирований: 2ABINanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation
Ashok Kumar Bishoyi, Sina Nouri, Ahmed Hussen +3
Обзорная статья2025Цитирований: 2ABINon-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Chang, Nicholas R. Pannunzio, Noritaka Adachi +1
Обзорная статья2017Цитирований: 2ABIEpigenetic Therapeutics: A New Weapon in the War Against Cancer
Nita Ahuja, Anup Sharma, Stephen B. Baylin
Обзорная статья2016Цитирований: 2ABI